Abstract | BACKGROUND: METHODS: Ki-67 was assessed using immunohistochemistry from paraffin-embedded tissue in 20 patients with uterine LMS, 22 cases of STUMP and 25 cases of leiomyomas. RESULTS: Ki-67 was present in 10/20 (50%) LMS, in 0/22 (0%) STUMP and in 2/25 (8%) leiomyomas. Significant differences regarding the frequency of Ki-67 expression were observed between LMS and STUMP (p = 0.0001) as well as between LMS and leiomyomas (p = 0.002), but not between STUMP and leiomyomas (p = 0.491). Likewise, the staining intensity differed significantly between LMS and leiomyomas (p = 0.018) as well as between LMS and STUMP (p = 0.002), but not between STUMP and leiomyomas (p = 0.368). CONCLUSIONS: Our results demonstrate that the significantly elevated Ki-67 antigen expression in LMS, which correlates well with the rapid growth of these malignant tumors, may be a useful immunohistochemical parameter to distinguish between cases of malignant smooth muscle tumors and those of uncertain or borderline histology.
|
Authors | Klaus Mayerhofer, Plamen Lozanov, Klaus Bodner, Barbara Bodner-Adler, Oliver Kimberger, Klaus Czerwenka |
Journal | Acta obstetricia et gynecologica Scandinavica
(Acta Obstet Gynecol Scand)
Vol. 83
Issue 11
Pg. 1085-8
(Nov 2004)
ISSN: 0001-6349 [Print] United States |
PMID | 15488127
(Publication Type: Comparative Study, Evaluation Study, Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Ki-67 Antigen
|
Topics |
- Adult
- Aged
- Biomarkers, Tumor
(blood)
- Female
- Humans
- Immunohistochemistry
- Ki-67 Antigen
(blood)
- Leiomyoma
(blood, diagnosis)
- Leiomyosarcoma
(blood, diagnosis)
- Middle Aged
- Neoplasms, Muscle Tissue
(blood, diagnosis)
- Predictive Value of Tests
- Retrospective Studies
- Smooth Muscle Tumor
(blood, diagnosis)
- Uterine Neoplasms
(blood, diagnosis)
|